• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

作者信息

Giesen A, Devos G, Everaerts W, Joniau S

机构信息

Department of Urology, UZ Leuven, Leuven, Belgium.

Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

出版信息

J Urol. 2024 Oct;212(4):626-627. doi: 10.1097/JU.0000000000004127. Epub 2024 Jul 8.

DOI:10.1097/JU.0000000000004127
PMID:38973715
Abstract
摘要

相似文献

1
Letter: A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.信函：新辅助化学激素疗法与激素疗法在接受根治性前列腺切除术的局部晚期前列腺癌治疗中的前瞻性随机试验
J Urol. 2024 Oct;212(4):626-627. doi: 10.1097/JU.0000000000004127. Epub 2024 Jul 8.
2
[Radical prostatectomy with neoadjuvant hormone therapy for cT3 prostate cancer].[新辅助激素治疗联合根治性前列腺切除术治疗cT3期前列腺癌]
Nihon Rinsho. 2005 Feb;63(2):271-8.
3
Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.新辅助化疗联合根治性前列腺切除术及扩大盆腔淋巴结清扫术治疗极高危局部晚期前列腺癌：一项回顾性比较研究
Urol Oncol. 2019 Dec;37(12):991-998. doi: 10.1016/j.urolonc.2019.07.009. Epub 2019 Aug 27.
4
Neoadjuvant hormonal therapy in carcinoma of the prostate.前列腺癌的新辅助激素治疗
BJU Int. 1999 Mar;83(4):438-48. doi: 10.1046/j.1464-410x.1999.00953.x.
5
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.单中心研究：新辅助化疗和激素治疗联合根治性前列腺切除术治疗高危前列腺癌患者的总生存。
Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5.
6
Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.新辅助雌莫司汀和依托泊苷联合根治性前列腺切除术治疗局部晚期前列腺癌的II期试验
Urology. 2001 Feb;57(2):281-5. doi: 10.1016/s0090-4295(00)00914-6.
7
[Neoadjuvant hormonal therapy for prostate cancer].[前列腺癌的新辅助激素治疗]
Gan To Kagaku Ryoho. 2001 Jul;28(7):927-33.
8
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.新辅助化疗联合激素治疗与根治性前列腺切除术后扩大盆腔淋巴结清扫术治疗高危前列腺癌患者的成本效果比较：多机构分析。
Med Oncol. 2017 Oct 31;34(12):190. doi: 10.1007/s12032-017-1050-y.
9
A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.新辅助化疗联合雄激素剥夺治疗对比单纯雄激素剥夺治疗局部进展期前列腺癌根治术后的前瞻性随机临床试验
J Urol. 2024 May;211(5):648-655. doi: 10.1097/JU.0000000000003876. Epub 2024 Apr 9.
10
Efficacy and safety of combination neoadjuvant chemo-hormonal therapy and robot-assisted radical prostatectomy for oligometastatic prostate cancer.新辅助化疗联合激素治疗与机器人辅助根治性前列腺切除术治疗寡转移前列腺癌的疗效和安全性
Int J Urol. 2024 Jul;31(7):826-828. doi: 10.1111/iju.15448. Epub 2024 Mar 7.